Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject
Clinical trial NCT02159599 · COMPLETED
Trial details
- NCT number
- NCT02159599
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-04-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.